Phase I/II Study of Ixazomib and Romidepsin in Relapsed/Refractory Peripheral T-cell Lymphoma (PTCL): Big Ten Cancer Research Consortium BTCRC-HEM15-028
|Effective start/end date||9/1/18 → 8/30/22|
- BIG TEN CANCER RESEARCH CONSORTIUM
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.